Fredun Pharmaceuticals Ltd.

View in App
774.55 -14.75 ▼-1.9%

18 April 2024, 04:01:00 PM
Volume: 4,540

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fredungroup.com
Market Cap 365.72 Cr.
Enterprise Value(EV) 428.75 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 30.61 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 25.30 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 252.22 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.07 Calculated using Price: 774.55
Dividend Yield 0.09 Period Ending 2023-03
No. of Shares Subscribed 0.47 Cr. 4,721,662 Shares
FaceValue 10
About Fredun Pharmaceuticals Ltd.
The company is engaged in manufacturing of pharmaceutical products.

Fredun Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Fredun Pharmaceuticals Ltd. Performance

View details >>
1 Day
-1.87%
1 Week
-2.77%
1 Month
+6.66%
3 Month
-8.22%
6 Month
-9.50%
1 Year
-14.79%
2 Year
-16.14%
5 Year
+69.52%
10 Year

Fredun Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.68 33.46 33.88 13.02 14.59 4.74 4.77 11.42 13.86
Return on Capital Employed (%) 14.23 24.67 18.16 15.9 20.56 10.36 9.53 13.15 18.35
Return on Assets (%) 1.26 3.23 2.88 2.59 4.84 1.54 1.33 3.63 4.86

Fredun Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 4 7 22 39 41 43 68 96 111
Non Curr. Liab. 4 7 8 4 13 14 32 45 55 20
Curr. Liab. 16 32 40 53 53 86 86 74 106 147
Minority Int.
Equity & Liab. 23 43 56 79 105 141 162 187 257 279
Non Curr. Assets 10 15 21 28 32 32 32 34 41 45
Curr. Assets 13 28 35 51 73 109 130 153 216 234
Misc. Exp. not W/O 0
Total Assets 23 43 56 79 105 141 162 187 257 279

Fredun Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 25 42 57 60 97 113 134 224 275 311
Other Income 0 1 2 0 1 1 1 2 2
Total Income 26 43 59 60 98 113 135 226 277 311
Total Expenditure -24 -38 -53 -54 -87 -104 -125 -211 -246 -271
PBIDT 2 5 5 6 11 9 11 16 31 40
Interest -1 -2 -2 -2 -3 -4 -4 -5 -10 -13
Depreciation -1 -1 -1 -1 -1 -2 -2 -2 -3 -4
Taxation 0 -1 -1 -1 -2 -1 -1 -2 -7 -9
Exceptional Items 0 0 -1
PAT 0 1 1 2 4 2 2 6 11 14
Adjusted EPS 1 4 5 4 11 5 5 14 24 31

Fredun Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 2 3 4 17 1 -11 0 -2 -14
Cash Fr. Inv. -2 -3 -6 -7 -8 -5 -1 -1 -4 -9
Cash Fr. Finan. 2 1 3 3 -8 4 14 -1 7 25
Net Change 0 0 1 -1 1 0 2 -2 1 1
Cash & Cash Eqvt 0 1 1 1 1 1 3 1 2 3

Fredun Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 51.27 51.04 51.04 50.34 50.15 49.62 49.31 49.16 49.13
Public 48.73 48.96 48.96 49.66 49.85 50.38 50.69 50.84 50.87
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Fredun Pharmaceuticals Ltd. Announcements

View details >>
Mon, 15 Apr 2024
Board Meeting Outcome for Allotment Of 20 000 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares
Allotment of 20 000 Equity Shares to Non-Promoter upon conversion of Warrants into Equity Shares
Mon, 15 Apr 2024
Compliance Certificate For The Period Ended March 31 2024
Compliance certificate for the period ended March 31 2024
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under reg 74(5) of SEBI (DP) Reg 2018

Fredun Pharmaceuticals Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
High Delivery Percentage High Delivery Percentage
High Increase in 1 Month High Increase in 1 Month
Close Below Last Week Low Close Below Last Week Low
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Near 20 SMA Closing Near 20 SMA

Fredun Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,523.80 -0.9%
Cipla Ltd. 108,808.58 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,959.10 -1.5%
Divi's Laboratories Ltd. 98,683.96 3,717.35 -1.3%
Mankind Pharma Ltd. 96,037.07 2,397.40 +5.0%
Zydus Lifesciences Ltd. 94,213.69 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,107.00 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 29.34 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,107.00 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 4.20 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,107.00 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,107.00 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,107.00 -3.6%

Fredun Pharmaceuticals Ltd. FAQ's

What is Fredun Pharma share price?
Can I buy Fredun Pharma shares now?
What is the Dividend Yield of Fredun Pharma?
What is the Market Cap of Fredun Pharma?
What are the key metrics to analyse Fredun Pharma?
What is the 52 Week High and Low of Fredun Pharma?
What is the trend of Fredun Pharma share price?